BIOPHARMA CONCLAVE 2019
The Indian biotechnology sector is highly innovative and exponential growth momentum. This sector plays a significant role in enhancing India's global profile along with immense contribution to country's growth economy. India is among the top 12 biotech destinations in the world and ranks 3rd in the Asia-Pacific region. India has the 2nd highest number of US Food and Drug Administration (USFDA) approved plants, after the USA and is the largest producer of recombinant Hepatitis B vaccine. With pharmaceutical industry, dwelling on the growth trajectory, the industry is moving its pace in the Biopharma segment. The move towards more transparent and stringent regulatory regime globally, the Biopharma industry is contributing enormously to health care sector.
With the wide patient population and low manufacturing costs, the India remains an attractive destination for the international Biopharma players. Considering the complexity involved in large molecule development it is extremely crucial to ensure right research and development support, quality assurance and control concerns, fostering innovation environment, developing cutting-edge cost effective products along correct marketing and launch strategies for the lucrative global market.
Considering all these factors, CPhI Conferences is pleased to launch the premier edition of Biopharma Conclave 2019 scheduled on 26th-27th September at The St. Regis, Mumbai. This 2-day comprehensive summit will deliberate on varied aspects such as on Biologics, Gene Therapy, Vaccines, Biosimilars, Biomanufacturing, Intellectual Property Rights, Commercialization and Marketing Strategies in biopharma domain. The objective of this conclave is to enlighten the biopharma professionals with latest trends, address the key challenges and enhance their skills to launch quality drugs in the global market. With case studies, innovation showcases and interactive panel discussions, utilize this exciting opportunity to meet and hear from the movers and shakers in the industry.
STEERING COMMITTEE MEMBERS & SPEAKERS
Dr. Sarfaraz K. Niazi, SI, FRSB, FPAMS, FACB
Founder, Karyo Biologics, Adello Biologics and PharmaSci, Adj Prof.
University of Illinois and University of Houston
Dr. Christiane Niederlaender
MHRA Senior Assessor and EMA CAT member
World Health Organization
Dr. Maharaj Sahib
Dr. Himanshu Gadgil
Whole – time director and CSO
Enzene Biosciences Ltd.
Dr. Raymond De Vré
Global Head – Biologics
Dr. Reddy’s Laboratories
Dr. Narendra Chirmule
Former Senior VP R&D
Dr. Anurag S. Rathore
Professor, Department of Chemical Engineering
Indian Institute of Technology, Delhi
Serum Institute of India Pvt. Ltd.
Dr. Sridevi Khambhampaty
Vice President, Biopharma Division
Intas Pharmaceuticals Ltd.
Dr. Disha Dadke, Ph. D.
Vice-President - Analytical, Regulatory, and Clinical Strategy
Aurobindo Biologics (a division of Aurobindo Pharma Ltd.), Hyderabad
Dr. Sanjeev Gupta
General Manager & Head-Advanced Biotech (R&D)
Dr. Parisa Asvadi, PhD RAC
Founder & Chief Consultant
Vida Biologics Consulting
Dr. Devesh Bhardwaj
Head Biotechnology R&D
Dr. Taslimarif Saiyed
CEO and Director
Centre for Cellular and Molecular Platforms (C-CAMP)
Dr. Ratnesh Jain
UGC Assistant Professor and Ramalingaswami Fellow Department of Chemical Engineering
Institute of Chemical Technology
Dr. Pradeep Nagalkar
Head of Quality Control
Haffkine Biopharmaceutical Corp. Ltd.
Dr. Hanmant Barkate
Vice President & Head-Medical Affairs
Glenmark Pharmaceuticals Ltd.
Head of Business Development and Licensing
Dr. Ranjan Chakravarti
Vice President and Head
Global Biologics Lab and Standards, United States Pharmacopeia
Dr. Annu Uppal
Scientific Affairs-Global Biologics
Better understanding of global and Indian regulatory guidelines along with global harmonization of drug approval
To address the key challenges like patents, manufacturing issues, clinical trials and approvals
Discuss the various solutions around the tedious process and price reduction mechanism
Deliberate on crucial and the most relevant topics to enlighten the bio-pharma professionals in this domain
Live case studies, innovation showcases and interactive panel discussions from the movers and shakers in the industry to deal with our key hassles
Encourage Innovation to launch newer Biologics and tackling problems right from research and development to manufacturing phase
TOP 5 REASONS TO PARTNER